Andrew Charles Perich, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3560 Route 309, St Lukes Physical Therapy, Orefield, PA 18069 Phone: 610-366-8502 Fax: 610-366-8508 |
Kristen Frey, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3560 Route 309, Orefield, PA 18069 Phone: 484-426-2005 |
Ms. Lisa Farrell Dolan, LPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6209 Vista Ter, Orefield, PA 18069 Phone: 610-530-0950 Fax: 414-908-7369 |
Cody Brenneman, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3560 Pa-309, Orefield, PA 18069 Phone: 484-426-2005 Fax: 610-366-8508 |
Ms. Gail Combs, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5722 Ricky Ridge Trl, Orefield, PA 18069 Phone: 610-336-4593 |
Christine Symonds Berger, PT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5255 Creekview Dr, Orefield, PA 18069 Phone: 610-704-4231 |
News Archive
A new bioRxiv preprint attempts to make some sense of why certain people experience more severe forms of COVID-19 as compared to others by pointing to the increase in virus binding that occurs in the presence of smoking or vaping.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
Medtronic announced today that the company was named a 2010 Medical Device Excellence Award winner for excellence in medical device design for its Hydrodebrider System, manufactured by the company's Ear Nose and Throat business unit.
For some time, researchers have known about disparities in diagnoses and outcomes among breast cancer patients based on race and age. However, they have been challenged to develop a set of criteria that can be used to reliably target drug delivery mechanisms based on an individual patient's tumor.
› Verified 5 days ago